Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
Marios C Pantzaris, Christos Bakirtzis, Nikolaos Grigoriadis, Georgios Hadjigeorgiou, Efthimos Dardiotis, George Loucaides, Evangelia Ntzani, Georgios Markozannes, Savvas Omorfos, Paola Valsasina, Roberta Messina, Paolo Preziosa, Maria A Rocca, Ioannis Patrikios
BMJ Neurology Open Nov 2022, 4 (2) e000334; DOI: 10.1136/bmjno-2022-000334